Exploring Potential Longevity Applications of Rapamycin With ChatGPT

#artificialintelligence 

In 2020 I joined the private beta test of Open AI's Generative Pre-trained Transformer 3 (GPT-3), which is an earlier version of ChatGPT. When ChatGPT was released in November 2022, I started experimenting with it. Large language models like ChatGPT are expected to enable a new wave of research, creativity and productivity, because they can help generate solutions for complex problems. For over two years I've been exploring the strengths and limits of this technology and assessing how this tool could be useful to me. I'm also interested how this new technology is being utilized by scientists to make meaningful contributions to academic work.

Duplicate Docs Excel Report

Title
None found

Similar Docs  Excel Report  more

TitleSimilaritySource
None found